You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

inotuzumab%20ozogamicin

Showing 1 - 25 of 117
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Lymphoblastic Leukemia Trial (inotuzumab ozogamicin)

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • inotuzumab ozogamicin
  • (no location specified)
Jan 6, 2023

ALL, MRD-positive, Hematopoietic Stem Cell Transplantation Trial in Suzhou (Inotuzumab Ozogamicin)

Recruiting
  • ALL
  • +2 more
  • Inotuzumab Ozogamicin
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Jul 14, 2023

ACUTE LYMPHOBLASTIC LEUKEMIA Trial (Inotuzumab ozogamicin, ALLR3)

Not yet recruiting
  • ACUTE LYMPHOBLASTIC LEUKEMIA
  • (no location specified)
Feb 17, 2023

Patients Who Received Inotuzumab Ozogamicin for B-cell ALL That

Not yet recruiting
  • Adult Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia
  • Inotuzumab Ozogamicin
  • (no location specified)
Nov 3, 2022

Leukemia Trial in Houston (Cyclophosphamide, Vincristine, Blinatumomab)

Not yet recruiting
  • Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Dec 23, 2022

Ph+ ALL, Bone Marrow Transplant, Minimal Residual Disease Trial in Tianjin (the usage of Olverembatinib combined with Inotuzumab

Not yet recruiting
  • Ph+ ALL
  • +2 more
  • the usage of Olverembatinib combined with Inotuzumab Ozogamicin
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital, Chinese Acade
Oct 30, 2022

Precursor Cell Lymphoblastic Leukemia Trial in Germany (Inotuzumab ozogamicin)

Recruiting
  • Precursor Cell Lymphoblastic Leukemia
  • Inotuzumab ozogamicin
  • Augsburg, Germany
  • +13 more
Oct 31, 2022

Acute Lymphocytic Leukemia Trial (Inotuzumab ozogamicin)

Not yet recruiting
  • Acute Lymphocytic Leukemia
  • Inotuzumab ozogamicin
  • (no location specified)
Jul 11, 2022

B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma Trial (Cyclophosphamide, Vincristine, Dexamethasone)

Not yet recruiting
  • B Acute Lymphoblastic Leukemia
  • B Lymphoblastic Lymphoma
  • (no location specified)
Aug 2, 2022

Acute Lymphoblastic Leukemia, Hyperbilirubinemia Trial in Houston (Levocarnitine, Vitamin B Complex)

Recruiting
  • Acute Lymphoblastic Leukemia
  • Hyperbilirubinemia
  • Levocarnitine
  • Vitamin B Complex
  • Houston, Texas
    M D Anderson Cancer Center
Nov 7, 2022

Infective Complications and Outcome of ALL Treated With INO

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +4 more
    • (no location specified)
    Aug 29, 2023

    Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, ph+ Acute Lymphoblastic Leukemia Trial in Chicago (Inotuzumab ozogamicin,

    Recruiting
    • Lymphoblastic Leukemia
    • +2 more
    • Inotuzumab ozogamicin
    • +7 more
    • Chicago, Illinois
      University of Chicago Medical Center
    May 16, 2022

    B-cell Acute Lymphoblastic Leukemia Trial in United States (Inotuzumab ozogamicin, Prednisone Pill, Daunorubicin)

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • Inotuzumab ozogamicin
    • +6 more
    • Nashville, Tennessee
    • +3 more
    Aug 14, 2022

    Besponsa Post Marketing Surveillance Study

    Active, not recruiting
    • Hematologic Maligmancy
    • Inotuzumab ozogamicin
    • Seoul, Korea, Republic of
      Pfizer
    Oct 10, 2022

    B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

    Completed
    • B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Mar 25, 2022

    InO - A Retrospective Study of UK Patients With Leukaemia

    Completed
    Has Results
    • Precursor Cell Lymphoblastic Leukemia-Lymphoma
    • Inotuzumab Ozogamicin
    • Bristol, United Kingdom
    • +3 more
    Jan 27, 2022

    Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Blasts 5 Percent or More of Bone Marrow Nucleated Cells, Blasts 5

    Withdrawn
    • Allogeneic Hematopoietic Stem Cell Transplantation Recipient
    • +7 more
    • Inotuzumab Ozogamicin
    • +2 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Jan 13, 2022

    B-cell Acute Lymphoblastic Leukemia, B-Cell Lymphoma, ALL Trial in Boston (Venetoclax, Dexamethasone, Inotuzumab Ozogamicin)

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • +2 more
    • Boston, Massachusetts
    • +1 more
    Oct 19, 2021

    Acute Lymphoblastic Leukemia Trial (chidamide, Venetoclax Oral Tablet, Inotuzumab Ozogamicin)

    Not yet recruiting
    • Acute Lymphoblastic Leukemia
    • (no location specified)
    Oct 19, 2023

    CD22 Positive, Recurrent Acute Lymphoblastic Leukemia, Refractory Acute Lymphoblastic Leukemia Trial in Houston (Inotuzumab

    Terminated
    Has Results
    • CD22 Positive
    • +2 more
    • Inotuzumab Ozogamicin
    • Houston, Texas
      M D Anderson Cancer Center
    Mar 17, 2021

    Leukemia, Precursor b-Cell Lymphoblastic Leukemia-Lymphoma, ACUTE LYMPHOBLASTIC LEUKEMIA Trial in Worldwide (inotuzumab

    Active, not recruiting
    • Leukemia
    • +2 more
    • inotuzumab ozogamicin-dose level 2
    • Inotuzumab ozogamicin-dose level 1
    • Los Angeles, California
    • +45 more
    Mar 9, 2022

    Acute Lymphoid Leukemia Trial in Italy (Inotuzumab Ozogamicin (IO))

    Recruiting
    • Acute Lymphoid Leukemia
    • Inotuzumab Ozogamicin (IO)
    • Ancona, Italy
    • +29 more
    Dec 31, 2021

    Trial (Inotuzumab Ozogamicin)

    Approved for marketing
      • Inotuzumab Ozogamicin
      • (no location specified)
      May 14, 2020

      Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma, Refractory B Acute Lymphoblastic Leukemia Trial in

      Recruiting
      • Recurrent B Acute Lymphoblastic Leukemia
      • +3 more
      • Biospecimen Collection
      • +11 more
      • Birmingham, Alabama
      • +152 more
      Jan 30, 2023

      Acute Lymphoblastic Leukemia Trial (Tisagenlecleucel, Blinatumomab, Inotuzumab)

      Withdrawn
      • Acute Lymphoblastic Leukemia
      • Tisagenlecleucel
      • +2 more
      • (no location specified)
      Jul 7, 2020